SUMMARY 16 17
Dopamine modulates the size of striatal projection neuron ensembles
Dopamine (DA) is a critical modulator of brain circuits that control voluntary movements, but our 18 understanding of its influence on the activity of target neurons in vivo remains limited. Here, we 19 use two-photon Ca 2+ imaging to simultaneously monitor the activity of direct and indirect-20 pathway spiny projection neurons (SPNs) in the striatum of behaving mice during acute and 21 prolonged manipulations of DA signaling. We find that, contrary to prevailing models, DA does 22 not modulate activity rates in either pathway strongly or differentially. Instead, DA exerts a 23 prominent influence on the overall number of direct and indirect pathway SPNs recruited during 24
behavior. Chronic loss of midbrain DA neurons in a model of Parkinson's disease selectively 25 impacts direct pathway ensembles and profoundly alters how they respond to DA elevation. Our 26 results indicate that DA regulates striatal output by dynamically reconfiguring its sparse 27 ensemble code and provide novel insights into the pathophysiology of Parkinson's disease. 28 29 30
The neuromodulator dopamine (DA) is an essential component of basal ganglia circuits that 33 control goal-directed behaviors. Considerable evidence in humans, primates and rodents 34
implicates DA in the selection and execution of vigorous movement and in supporting motor 35 learning via its actions in striatum, the largest input nucleus of the basal ganglia (Graybiel 2005 ; 36 Turner & Desmurget 2010; Dudman & Krakauer 2016; Klaus et al., 2019) . In humans for instance, 37 loss of striatum-projecting midbrain DA neurons in Parkinson's disease is associated with 38 bradykinesia, while drugs that elevate DA act as stimulants and are behaviorally reinforcing. 39 Striatal output is mediated by two populations of inhibitory spiny projection neurons (SPNs) 40 belonging to the direct and indirect pathways (dSPNs and iSPNs). Although long believed to exert 41 opposite effects on movement, dSPNs and iSPNs are now known to be concurrently active and 42
to work in concert to produce coherent sequences of voluntary movements ( are, and if DA plays a role in sculpting them. Here, we test this possibility using two-photon Ca 2+ 65 imaging to monitor dSPN and iSPN ensembles simultaneously in the striatum of behaving mice. 66 We report that acute DA manipulations strongly modify the overall size of movement-related 67 dSPN and iSPN ensembles, while exerting comparatively little influence on the rate of Ca 2+ events. 68
In addition, we show that chronic loss of midbrain DA neurons in a model of Parkinson's disease 69
is associated with a specific decrease in the number of active dSPNs and with significant changes 70 in how dSPN ensembles respond to DA replacement. 71
RESULTS

73
Baseline activity in dSPNs and iSPNs is concurrent and balanced 74
To resolve the activity of individual striatal neurons in vivo, we performed two-photon 75 microscopy through a chronically implanted window (Howe & Dombeck 2016; Bloem et al., 2017) 76 in head-fixed mice (N = 18) on a freely rotating circular treadmill (Fig. 1a) . We GCaMP6f only ( Fig. 1b and Supplementary Video). 85
Self-paced forward locomotion was associated with prominent increases in fluorescence in 86 groups of neurons both positive and negative for tdTomato ( Fig. 1c) . Population Ca 2+ signals in 87 tdTomato-positive dSPNs resembled data obtained using photometry in mice expressing 88
GCaMP6f selectively in dSPNs ( Supplementary Fig. 1a ). Amongst tdTomato-negative neurons, 89
the vast majority resembled dSPNs in morphology and, when active, showed Ca 2+ transients 90 comparable to those observed in dSPNs ( Fig. 1e,f ) and activity consistent with signals obtained 91 specifically from iSPNs ( Supplementary Fig. 1b-d) . These cells were consequently classified as 92 iSPNs. A small fraction of tdTomato-negative neurons consistently exhibited distinct Ca 2+ 93
dynamics, suggesting that they represent striatal interneurons (Gritton et al., 2019; Howe et al., 94 2019). Indeed, the proportions of imaged neurons assigned to dSPNs, iSPNs and interneurons 95 agree with anatomical estimates (Fig. 1d ). This imaging approach therefore offers the ability to 96 simultaneously monitor and compare the activity of hundreds of striatal neurons (mean ± SEM): 97 327 ± 13 per FOV, range: 131-442) belonging to both direct and indirect pathways with high 98 spatial resolution during a simple behavior. 99
The fraction of all imaged dSPNs and iSPNs displaying Ca 2+ transients in each FOV across all 100 forward locomotor bouts were comparable across imaging sessions on separate days ( Fig. 1g,h contributing to each subset grew larger as treadmill speed increased without notable temporal 106 offset between pathways ( Fig. 1j,k) . The end of movement was associated with a progressive 107 decline in the fraction of active SPNs (Fig. 1k) . The frequency of Ca 2+ transients in individual SPNs 108 was also comparable across pathways and similarly reflected treadmill velocity ( Fig. 1l-n (DAT) fluorescence in dorsal striatum ( Fig. 2a,b and Supplementary Fig. 2a,b ). Consistent with 121
DA's established role in producing vigorous movement (Panigrahi et al., 2015) , unilateral SNc 122 lesions mildly reduced the mean velocity of self-paced locomotor bouts compared to sham-123 treated mice (N = 6; Two-way ANOVA lesion x time: F2,30 = 5.56, p = 0.009) as early as 24 hours 124
and for up to a month after treatment ( Supplementary Fig. 2c ), but not their duration (F2,30 = 125 0.99, p = 0.38; Supplementary Fig. 2d ) or frequency (F2,30 = 0.15, p = 0.86; Supplementary Fig.  126 2e). Lesioned mice also showed a strong and persistent ipsiversive turning bias in a closed-arm 127 plus-maze (F2,27 = 6.0, p = 0.007; Fig. 2c ), further providing evidence of the immediate and long-128 lasting motor impairments that result from unilateral loss of SNc neurons. 129
A recent study using one-photon microendoscopy revealed that DA depletion results in large 130 and opposite changes in the frequency of Ca 2+ transients imaged from dSPNs and iSPNs in 131 separate cohorts of freely behaving mice (Parker et al., 2018) . We therefore attempted to 132 replicate their findings under our experimental conditions by monitoring Ca 2+ signals in dSPNs 133 and iSPNs concurrently within the same FOV. We first confirmed that DA depletion (n = 21 FOVs 134 in 12 mice) did not compromise our ability to detect Ca 2+ transients, as their amplitude in dSPNs 135 and iSPNs did not significantly vary over imaging sessions compared to sham-treated mice (n = 9 136
FOVs in 6 mice; Two-way ANOVA lesion x time: dSPN: F2,45 = 1.31, p = 0.3; iSPN: F2,45 = 1.50, p = 137 0.2; Supplementary Fig. 3a-c) , excluding shifts in signal-to-noise as primary contributors to 6-138
OHDA-mediated phenotypes. In agreement with Parker and colleagues (2018), we observed a 139 significant effect of 6-OHDA on the overall rate of Ca 2+ events imaged across the entire FOV (i.e. 140 population-level Ca 2+ event rate) in both dSPNs (Two-way ANOVA lesion x time: F2,45 = 3.95, p = 141 0.026) and iSPNs (F2,45 = 14.84, p = 1.12 x 10 -5 ) compared to vehicle-treated mice. Striatal activity 142 did not appreciably change in sham-treated mice, establishing a stable baseline from which to 143 identify differences specifically related to the loss of DA neurons. By contrast, population-level 144 rates in dSPNs decreased by half during locomotion immediately after 6-OHDA infusion, while 145 they more than doubled in iSPNs at all recorded velocities ( Fig. 2d-i) . Population-level Ca 2+ event 146 rates in chronically lesioned mice remained depressed in dSPNs but returned to baseline in iSPNs 147 during movement ( Fig. 2d-i) , consistent with previous observations (Parker et al., 2018) . These 148 results therefore indicate that DA depletion strongly biases striatum-wide activity towards the 149 indirect pathway both acutely and chronically in head-fixed and freely-moving mice. However, 150 they do not clearly establish how these population-level effects arise. We investigate this in the 151 following section. 152 153
Lesioning DA neurons differentially alters dSPN and iSPN ensemble size 154
The population-level Ca 2+ event rate changes reported in Fig. 2 may result from changes in 155 the frequency of Ca 2+ transients experienced by individual SPNs, differences in the overall size of 156 SPN ensembles recruited by a given behavior, or both ( Fig. 3a) . To distinguish between these 157 possibilities, we took advantage of the high spatial resolution and signal-to-noise of two-photon 158 microscopy (Helmchen & Denk 2005) . Given our reported effects on frequency ( Fig. 2) detect a significant effect of 6-OHDA compared to sham in either dSPNs (Two-way ANOVA lesion 163
x time: F2,45 = 1.05, p = 0.36; Fig. 3b ) or iSPNs (F2,45 = 1.64, p = 0.21; Fig. 3c ) across recorded 164 treadmill velocities ( Fig. 3e) . Because the mean Ca 2+ transient frequency per active iSPN trended 165 up immediately after 6-OHDA infusion and trended down in dSPNs in chronically lesioned mice, 166
DA depletion did result in a slight imbalance in activity rates towards the indirect pathway (F2,45 167 = 7.98, p = 0.001; Fig. 3d ). However, this effect alone cannot account for the strongly 168 dichotomous behavior of dSPNs and iSPNs reported above ( Fig. 2) and before (Parker et al., 169 2018). 170
We therefore considered the alternative possibility that lesioning DA neurons alters the size 171 of SPN ensembles associated with forward locomotion. Indeed, we observed a strong effect of 6-172
OHDA on ensemble size compared to vehicle-injected mice in dSPNs (Two-way ANOVA lesion x 173 time: F2,53 = 3.66, p = 0.03; Fig. 3f ), iSPNs (F2,53 = 11.92, p = 5.3 x 10 -5 ; Fig. 3g ) and in pathway bias 174 (F2,53 = 19.0, p = 6.1 x 10 -7 ; Fig. 3h ). Specifically, the total number of dSPNs displaying Ca 2+ 175 transients over the course of an imaging session was halved immediately after 6-OHDA infusion 176 and remained low thereafter ( Fig. 3f) . This is unlikely to result from diminished locomotor speed 177 because within the same FOV, the total number of active iSPNs and the subset of iSPNs recruited 178 per locomotor bout doubled in acutely lesioned mice ( Fig. 3g ) across recorded velocities (Fig. 3i ) 179 and movement bouts ( Fig. 3j ). In addition, imaging sessions on motorized treadmills with 180 constant velocity and distance traveled yielded similar results ( Supplementary Fig. 3j-l) . Acute 181 loss of SNc neurons therefore alters the extent of dSPN and iSPN ensembles in opposite ways, 182 generating a strong imbalance in favor of the indirect pathway ( Fig. 3h) . Interestingly, the 183 expansion of iSPN ensembles was not sustained in time and returned to baseline in chronically 184 lesioned animals ( Fig. 3f-j) . Because compensatory changes were not observed in dSPNs, the 185 overall size of SPN ensembles recruited over the course of imaging sessions remained 186 significantly biased towards the indirect pathway in chronically lesioned mice ( Fig. 3h) bouts compared to vehicle-treated animals ( Supplementary Fig. 4a-c) . We therefore limited our 197 analyses to imaging sessions on motorized treadmills to keep velocity and distance traveled 198 constant. 199
Consistent with our earlier findings, reducing DA signaling did not change the frequency of 200 Ca 2+ transients in individual dSPNs recruited by forward locomotion (p = 0.2, Mann-Whitney; 201 vehicle: n = 10 FOVs in 5 mice; DA antagonist: n = 11 FOVs in 5 mice; Fig. 4a ). The frequency of 202 Ca 2+ transients in iSPNs increased (p = 0.007, Mann-Whitney; Fig. 4b ), but not enough to bias 203 striatal activity towards the indirect pathway (p = 0.22, Mann-Whitney; Fig. 4c ). In stark contrast, 204
blocking DA receptors significantly affected SPN ensemble size: it reduced the total number of 205 dSPNs recruited by forward locomotion by half (p = 0.006, Mann-Whitney; Fig. 4d ) and expanded 206 iSPNs more than three-fold (p = 5.7 x 10 -6 , Mann-Whitney; Fig. 4e ), leading to a strong imbalance 207 in favor of the indirect pathway (p = 5.7 x 10 -6 , Mann-Whitney; Fig. 4f ). These data indicate that 208 loss of DA minimally impacts the frequency of Ca 2+ transients displayed by SPNs, yet it evokes 209 substantial reconfiguration of the overall number of dSPNs and iSPNs associated with a given 210 behavior. 211
We next investigated whether elevating DA signaling would exert the opposite effect. To do 212 so, we imaged striatal activity upon pharmacological stimulation of D1 and D2 receptors (n = 11 213
FOVs in 7 mice) while mice locomoted on motorized treadmills to mitigate treatment effects on 214 spontaneous behavior (Supplementary Fig. 4a-c) . Here too, we failed to detect changes in the 215 frequency of Ca 2+ transients during locomotion in individual dSPNs (p = 0.9, Mann-Whitney; Fig.  216 4a) or between pathways (p = 0.36, Mann-Whitney; Fig. 4c ), despite a small but statistically 217 significant decrease in Ca 2+ transient frequency in iSPNs compared to vehicle (p = 0.021, Mann-218 Whitney; Fig. 4b ). By contrast, stimulating DA receptors markedly altered the size of SPN 219 ensembles associated with forward locomotion, yielding a strong imbalance in favor of the direct 220 pathway (p = 2.0 x 10 -4 , Mann-Whitney; Fig. 4f ). The latter was mediated by a near complete 221 decline in the prevalence of active iSPNs (p = 2.3 x 10 -5 , Mann-Whitney; Fig. 4e ) since, contrary 222 to DA's presumed excitatory influence on dSPNs, activation of DA receptors also diminished the 223 number of active dSPNs (p = 0.015, Mann-Whitney; Fig. 4d ). Importantly, mild elevation of 224 endogenous DA using the presynaptic DA reuptake antagonist nomifensine similarly diminished 225 the number of active dSPNs without altering Ca 2+ transient frequency ( Supplementary Fig. 4d , 226 e). Together, these data indicate that DA does not strongly modulate the frequency of Ca 2+ 227 transients in individual dSPNs and iSPNs that comprise action-specific ensembles. Instead, DA 228 controls the number of SPNs recruited with each motor action as well as the extent of the larger 229 SPN ensembles that are defined over multiple rendition of such action. While the overall number 230 of iSPNs recruited in this task is inversely related to extracellular DA, dSPNs follow an 'inverted-231 U' shaped function, where too little or too much DA negatively impacts the size of their ensemble. 232 233
Chronic DA depletion alters how SPN ensembles respond to DA 234
Motor impairments in Parkinson's disease are typically managed by elevating striatal DA with 235 L-DOPA, the metabolic precursor for DA. We therefore wondered whether acutely restoring DA 236 with L-DOPA would affect SPN ensemble size, and if so how. To address this, we treated a subset 237 of the mice (N = 6) that had received unilateral vehicle or 6-OHDA infusions in SNc a month or 238 more earlier with a single dose of L-DOPA. As expected, this treatment had a significant effect on 239 the behavior of 6-OHDA vs. sham-lesioned mice (N = 5) in the plus-maze (Two-way ANOVA lesion 240
x levodopa: F1,18 = 94.7, p = 1.4 x 10 -8 ), reversing the turning bias of lesioned mice within minutes 241 (p = 6.2 x 10 -10 , post-hoc Bonferroni; Fig. 5a ). In the striatum of DA-depleted mice locomoting on 242 motorized treadmills (n = 12 FOVs), L-DOPA elevated the frequency of Ca 2+ transients in individual 243 dSPNs and reversed the mild frequency imbalance caused by DA depletion (Fig. 5c ), in agreement 244 with previous work (Parker et al., 2018) . In addition and most notably, L-DOPA significantly 245 altered the size of SPN ensembles ( Fig. 5b) : it halved the overall number of iSPNs exhibiting Ca 2+ 246 transients and expanded the number of active dSPNs 10-fold, reaching upwards of 70% of all 247 imaged dSPNs in some FOVs (Fig. 5d) . This resulted in a reversal of ensemble size imbalance in 248 DA-depleted mice towards the direct pathway ( Fig. 5d) . These data therefore indicate that DA 249 favors the recruitment of dSPNs relative to iSPNs in both DA-intact and DA-depleted mice, but 250 that the underlying mechanisms profoundly differ ( Fig. 5e) . 251
DISCUSSION
253
In this study, we sought to reveal how acute and prolonged manipulations of DA signaling impact 254 striatal output. To do so, we simultaneously monitored intracellular Ca 2+ signals in dSPNs and 255 iSPNs using two-photon microscopy to permit the identification of subtle imbalances between 256 SPN populations long proposed to lie at the heart of basal ganglia function and dysfunction 257 ( and colleagues (2018) did not detect mean firing rate differences in iSPNs during movement in 297 chronically lesioned mice, in line with our findings (Fig. 3c) Fig. 1 were performed using offspring of 392
Adora2a Cre_KG139 mice bred to a tdTomato reporter (Ai14; The Jackson Laboratory, Stock #: 393 007908). Experiments were carried out using both male and female mice heterozygous for all 394 transgenes at 8-24 weeks of age. 395 396 Surgery. Mice were administered Dexamethasone (4 mg/kg, intraperitoneal) 1-2 hours prior to 397 surgery. They were then anaesthetized with isoflurane, placed in a stereotaxic apparatus (Kopf 398
Instruments) on a heating blanket (Harvard Apparatus) and administered Ketoprofen (10 mg/kg, 399 subcutaneous). The scalp was shaved and cleaned with ethanol and iodine solutions before 400 exposing the skull. A custom titanium headpost was implanted over lambda using C&B metabond 401
(Parkell) to allow head fixation. To achieve widespread viral expression of GCaMP6f in striatum, 402 100 nl of AAV1-Syn-GCaMP6f-WPRE-SV40 (University of Pennsylvania Vector Core) was injected 403 1.7 mm below dura at a rate of 100 nl/min (KD Scientific) into the right dorsolateral striatum at 404 four locations (anterior/lateral from bregma, in mm): 0.7/1.7; 0.7/2.3; 1.3/1.7 and 1.3/2.3. 405
Injection pipettes were left in place for 5 min before removal. A 3 mm craniotomy was then 406 drilled (centered at 1.0 mm anterior and 2.0 mm lateral from bregma) and cortical tissue was 407 aspirated until the corpus callosum lying above the striatum was exposed, as described previously 408 (Howe & Dombeck 2016) . A custom 9 gauge thin-walled stainless-steel cannula (Microgroup; 2.3 409 mm in height) sealed at one end with a 3 mm glass coverslip (Warner Instruments) using optical 410 glue (Norland #71) was placed above the striatum and cemented to the skull using C&B 411 metabond. Mice were allowed to recover in their cage for 2 weeks before head-fixation 412 habituation, treadmill training and imaging. in SNc (4.2 mm below dura) at a rate ~100 nl/min. Sham-lesioned mice were treated identically 421 except that 6-OHDA was omitted from the injected solution (0.2% ascorbic acid in 0.9% sterile 422 NaCl solution). To evaluate motor impairments, mice were placed in a plus maze consisting of 4 423 identical arms (45 cm × 7 cm × 15 cm) at 90° to each other and monitored from above with a near 424 infrared camera (Basler; acA2000-165um) for 10 min. The number of ipsiversive, contraversive 425 and straight choices upon reaching the center of the maze were automatically quantified in 426 MATLAB (Mathworks) and verified visually. Data were expressed as a turning bias index, defined 427 as the difference between ipsiversive and contraversive turns, divided by the total number of 428 turns. 429 430
Immunohistochemistry. Mice were deeply anesthetized with isoflurane and perfused 431 transcardially with 4 % paraformaldehyde in 0.1 M sodium phosphate buffer. Brains were post-432 fixed for 1-3 days, sectioned coronally (50-100 µm in thickness) using a vibratome (Leica; 433 VT1000S) and processed for immunofluorescence staining for tyrosine hydroxylase (Millipore; 434 AB152, 1:1000) and dopamine transporter (Millipore; MAB369, 1:1000) using standard methods. 435
Brain sections were mounted on superfrost slides and coverslipped with ProLong antifade 436 reagent with DAPI (Molecular Probes). Endogenous tdTomato and GCaMP6 fluorescence were 437 not immuno-enhanced. Whole sections were imaged with an Olympus VS120 slide scanning 438 microscope and high resolution images of regions of interest were subsequently acquired with a 439
Zeiss LSM 800 confocal microscope. TH and DAT immunofluorescence were quantified in ImageJ 440 (NIH) by measuring mean pixel intensity in similarly-sized regions of interest in VTA, SNc, dorsal 441 striatum and ventral striatum in both intact and lesioned hemispheres. After subtracting 442 background signal from adjacent unstained brain regions, fluorescence intensity values in the 443 lesioned hemisphere were expressed as a percentage of values measured on the intact side. 444
Three measurements were obtained from each region of interest along the anterior-posterior 445 axis and averaged together for each mouse. 446 447
Reagents. Drugs (all from Tocris, unless specified otherwise) were reconstituted and stored 448
according to the manufacturers' recommendations. 6-hydroxydopamine (6-OHDA; Sigma-449
Aldrich) was dissolved freshly into sterile 0.9% NaCl and 0.2% ascorbic acid immediately prior to 450 administration to minimize oxidation. Working concentration aliquots of desipramine (25 451 mg/kg), pargyline (Sigma-Aldrich; 5 mg/kg), S(-)raclopride (Sigma-Aldrich; 1 mg/kg), SCH23390 452 (Fisher Scientific; 0.2 mg/kg), nomifensine (10 mg/kg), (-)quinpirole (3 mg/kg), SKF81297 (3 453 mg/kg) and L-DOPA (10 mg/kg) were prepared daily in sterile physiological saline and 454 administered intraperitoneally at minimum 20 min prior to experimentation. fluorescence sources within 30 μm of the selected pixel were then identified automatically based 485 on the correlation structure of the pixel time series to delineate the spatial footprint of active 486 neuronal processes. Fluorescence time series were computed by averaging across all pixels 487
within that footprint and were manually classified into cell bodies, processes (not analyzed), and 488 background (neuropil). This approach is advantageous over manually defined regions of interest 489
as it segregates dendritic processes that overlap with somata if they exhibit distinct fluorescence 490 time series. Each putative cell was paired with a neighboring background source, which was 491 subtracted from the cell body's fluorescence time series. Segmentation and neuropil subtraction 492 were manually verified for each cell and adjusted when necessary using a graphical user interface 493
to obtain clean neuropil-subtracted fluorescence traces without apparent negative-going 494 transients. GCamp6f-labelled cell bodies were manually labeled as a dSPNs based on tdTomato 495 fluorescence in the mean intensity image, and tdTomato-negative cells were labeled as putative 496 iSPNs or 'other' (not analyzed) based on cell morphology, baseline Ca 2+ fluorescence intensity 497
and Ca 2+ transient kinetics ( Fig. 1 and Supplementary Fig. 1) by an experimenter blind to 498 experimental conditions. 499 500
Image and behavior analyses. Quantification of imaging and behavioral data was carried out in 501 MATLAB using custom-code available online (https://github.com/TritschLab). Ca 2+ transients 502
were detected using the built-in MATLAB findpeaks() function on each cell's neuropil-subtracted 503 fluorescence trace smoothed with a 150 ms window if they exhibited a minimum peak height 504 and minimum peak prominence of 5 standard deviations greater than baseline, and a minimum 505 width of 140 ms at half peak prominence. These criteria are intentionally stringent so as to 506 exclude events not clearly resolved from baseline fluorescence at the cost of underestimating 507
Ca 2+ transient frequency per SPN. Ca 2+ transient rise time is defined as the time required for 508 fluorescence to rise from 20 to 80 % of peak height, and decay time as the time required for 509 fluorescence to decay to one third of its peak. All imaged neurons displaying at minimum one 510 indicated in text and figure legends. Significant interactions were followed-up with within-group 548 pairwise t-tests with baseline or prelesion data corrected for multiple comparisons (Bonferroni). 549 P values smaller than 0.05 were considered statistically significant and assigned the following 550 nomenclature in Figures h. Same as g for iSPNs (p = 0.78; Wilcoxon signed-ranks).
i. Percentage of imaged dSPNs and iSPNs exhibiting Ca 2+ transients per FOV (n = 30). Mean  SEM shown in blue.
j. Percentage of all imaged dSPNs and iSPNs that display Ca 2+ transients at different treadmill velocities (n = 30 FOVs).
k. Percentage of all imaged dSPNs and iSPNs that display Ca 2+ transients aligned to locomotion onset (left) and offset (right) overlaid with treadmill velocity (black).
l. Mean Ca 2+ transient frequency in all active dSPNs vs. iSPNs (n = 30 FOVs) during spontaneous treadmill running (black) and while immobile (gray). No significant difference was observed between dSPNs and iSPNs while moving (blue; p = 0.8, Wilcoxon signedranks) or immobile (yellow; p = 0.4, Wilcoxon signed-ranks). b. Quantification of immunofluorescence signal for DAT in dorsal and ventral striatum (left) and TH in SNc and VTA (right) in sham (gray; N = 6) and 6-OHDA lesioned (blue; N = 12) mice on treated vs. intact hemispheres (mean ± SEM overlaid). Asterisks depict significant difference from sham (DS: p = 3.2 x 10 -4 ; VS: p = 0.001; SNc: p = 1.1 x 10 -4 ; VTA: p = 1.1 x 10 -4 ; Mann-Whitney).
c. Turning bias measured in a closed-arm plus maze from a subset of vehicle (N = 5, gray) and 6-OHDA injected (N = 6, blue) mice 1 day before, 1 day after and 30 days after intracranial injection surgery. Values approaching 1 and -1 reflect strong turning bias toward (ipsiversive) or away from (contraversive) the lesioned hemisphere, respectively. Withingroup post-hoc statistic (Bonferroni, vs. pre-surgery): Sham, day 1: p = 0.98; day 30: p = 0.28; 6-OHDA, day 1: p = 0.003; day 30: p = 0.015. . 2g, h. j. Percentage of dSPN and iSPN activated per self-initiated locomotor bout aligned to onset and offset before, 1 day after, or 30 days after 6-OHDA lesion. Note similarities with Fig. 2i . b. Same as a for iSPNs (antagonists: p = 0.007; agonists: p = 0.02; Mann-Whitney).
c. Same as a for bias in frequency between pathways (antagonists: p = 0.22; agonists: p = 0.36; Mann-Whitney).
d. Fraction of all imaged dSPNs active per FOV after systemic administration of vehicle (left; n = 10 FOVs in 5 mice), D1 and D2 receptor antagonists (middle; n = 11 FOVs in 5 mice, p = 0.006, Mann-Whitney) or D1 and D2 receptor agonists (right; n = 11 FOVs in 7 mice, p = 0.015, Mann-Whitney) normalized to pre-drug baseline.
e. Same as d for iSPNs (antagonists: p = 5.7 x 10 -6 ; agonists: p = 2.3 x 10 -5 ; Mann-Whitney).
f. Same as d for bias in ensemble size between pathways (antagonists: p = 5.7 x 10 -6 ; agonists: p = 2.0 x 10 -4 ; Mann-Whitney).
Mean ± SEM are overlaid for each group. Asterisks depict significant difference from vehicle. Right: frequency bias index. Mean ± SEM are overlaid for each group (dSPN: p = 0.023; iSPN: p = 0.052; pathway bias: p = 0.016; all vs. baseline, Wilcoxon signed rank).
d. Same as c for active SPN ensemble size (dSPN: p = 0.001; iSPN: p = 0.016; pathway bias: p = 4.9 x 10 -4 ; all vs. baseline, Wilcoxon signed rank). e. Summary diagrams depicting observed changes in SPN ensemble size in response to changing striatal DA levels in intact and DA-depleted mice. b. Number of TH-positive neurons identified in SNc and VTA on injection side relative to contralateral side 24 h after intracranial injection (VTA, p = 0.008; SNc, p = 0.004, n = 9 sections from 3 mice, Wilcoxon signed rank).
c. Quantification of mean self-initiated treadmill velocity before, 1 day after and 30 days after unilateral injection of vehicle (N = 6, gray) or 6-OHDA (N = 12, blue) in SNc. Within-group post-hoc statistics (Bonferroni, vs. pre-surgery) for velocity: sham, day 1: p > 0.99; day 30: p = 0.14. 6-OHDA, day 1: p = 0.035; day 30: p = 0.033. 
